
Indian company Gennova Biopharmaceuticals is working on a vaccine against the Omicron strain of coronavirus.
A source familiar with the matter told Reuters that the vaccine could be ready in as little as a month or two.
In addition, the source said the drug may need to undergo a small trial in India before it can be used as a booster or standalone vaccine.
About The Author
Elizabeth
Elizabeth Stone has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Quebec Telegram, Elizabeth Stone worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my stone@qtelegram.com 1-800-268-7116